patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Therapeutics' Dr. William Prather Interviewed on CorporateProfile.com

NEW YORK, NY--(Marketwire - 02/01/11) - Corporate Profile, LLC announced today that Pluristem Therapeutics, Inc. (NASDAQ:PSTI - News) VP of Corporate Development, Dr. William Prather, was interviewed on CorporateProfile.com.

The video can be viewed at: www.corporateprofile.com.

Share
New Message
Please login to post a reply